Invention Grant
US09242975B2 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
有权
用作激酶抑制剂的杂环取代的吡啶基化合物
- Patent Title: Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
- Patent Title (中): 用作激酶抑制剂的杂环取代的吡啶基化合物
-
Application No.: US14371456Application Date: 2013-01-11
-
Publication No.: US09242975B2Publication Date: 2016-01-26
- Inventor: Venkatram Reddy Paidi , Sreekantha Ratna Kumar , Abhisek Banerjee , Ramesh Sistla , Satheesh Kesavan Nair , William J. Pitts , John Hynes
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary D. Greenblatt
- International Application: PCT/US2013/021093 WO 20130111
- International Announcement: WO2013/106612 WO 20130718
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D413/14 ; C07D413/04 ; C07D417/04 ; C07D471/04 ; C07D471/10 ; C07D487/04
Abstract:
Compounds having the following formula: wherein A is, or; and X is N or C—R7, or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.
Public/Granted literature
- US20150011532A1 HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2015-01-08
Information query
